Recent Research Analysts’ Ratings Updates for Albemarle (ALB)

Several brokerages have updated their recommendations and price targets on shares of Albemarle (NYSE: ALB) in the last few weeks:

  • 5/14/2018 – Albemarle was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $110.00 price target on the stock. According to Zacks, “Albemarle’s adjusted earnings and sales for the first quarter beat the respective Zacks Consensus Estimate. The company raised its earnings outlook for 2018. Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong growth in the battery-grade lithium market. The company is also likely to gain from the synergies of Rockwood Holdings acquisition. Further, Albemarle is divesting non-core assets to boost growth opportunities and focus on its key businesses.”
  • 5/11/2018 – Albemarle had its price target lowered by analysts at Nomura to $130.00. They now have a “buy” rating on the stock.
  • 5/9/2018 – Albemarle was upgraded by analysts at TheStreet from a “c+” rating to a “b” rating.
  • 5/8/2018 – Albemarle was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong growth in the battery-grade lithium market. The company is also likely to gain from the synergies of Rockwood Holdings acquisition. Further, Albemarle is divesting non-core assets to boost growth opportunities and focus on its key businesses. Moreover, it remains committed to deliver incremental returns to shareholders. However, Albemarle is facing headwinds associated with its Bromine business and higher expected tax rate in 2018. Moreover, a significant rise in capital spending is expected to hurt its free cash flows this year. Albemarle has also underperformed the industry it belongs to over the last six months.”
  • 5/2/2018 – Albemarle was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $109.00 price target on the stock. According to Zacks, “Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong growth in the battery-grade lithium market. The company is also likely to gain from the synergies of Rockwood Holdings acquisition. Further, Albemarle is divesting non-core assets to boost growth opportunities and focus on its key businesses. Moreover, it remains committed to deliver incremental returns to shareholders.”
  • 4/17/2018 – Albemarle had its “buy” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $113.00 price target on the stock.
  • 4/13/2018 – Albemarle was upgraded by analysts at Citigroup from a “neutral” rating to a “buy” rating. They now have a $106.00 price target on the stock.
  • 4/12/2018 – Albemarle had its price target lowered by analysts at KeyCorp from $148.00 to $140.00. They now have an “overweight” rating on the stock.
  • 4/10/2018 – Albemarle had its price target lowered by analysts at Citigroup from $112.00 to $95.00. They now have a “neutral” rating on the stock.
  • 3/27/2018 – Albemarle had its price target lowered by analysts at Argus from $148.00 to $125.00. They now have a “buy” rating on the stock.

Albemarle opened at $104.80 on Friday, according to Marketbeat Ratings. The company has a current ratio of 2.48, a quick ratio of 1.72 and a debt-to-equity ratio of 0.36. The stock has a market cap of $11.34 billion, a price-to-earnings ratio of 22.83, a P/E/G ratio of 1.20 and a beta of 1.67. Albemarle Co. has a 52-week low of $101.15 and a 52-week high of $102.46.

Albemarle (NYSE:ALB) last issued its quarterly earnings data on Wednesday, May 9th. The specialty chemicals company reported $1.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.10. Albemarle had a net margin of 4.27% and a return on equity of 13.80%. The firm had revenue of $821.60 million for the quarter, compared to analysts’ expectations of $798.20 million. During the same quarter in the prior year, the business earned $1.05 EPS. The business’s quarterly revenue was up 13.8% on a year-over-year basis. analysts expect that Albemarle Co. will post 5.26 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 2nd. Stockholders of record on Friday, June 15th will be paid a $0.335 dividend. This represents a $1.34 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Thursday, June 14th. Albemarle’s dividend payout ratio (DPR) is presently 29.19%.

Large investors have recently modified their holdings of the company. SeaCrest Wealth Management LLC bought a new position in shares of Albemarle in the 4th quarter worth approximately $103,000. Stephens Inc. AR bought a new position in shares of Albemarle in the 4th quarter worth approximately $115,000. Dupont Capital Management Corp lifted its stake in shares of Albemarle by 81.6% in the 1st quarter. Dupont Capital Management Corp now owns 1,358 shares of the specialty chemicals company’s stock worth $126,000 after purchasing an additional 610 shares during the period. Banco de Sabadell S.A bought a new position in shares of Albemarle in the 4th quarter worth approximately $133,000. Finally, Valeo Financial Advisors LLC bought a new position in shares of Albemarle in the 4th quarter worth approximately $155,000. Hedge funds and other institutional investors own 84.73% of the company’s stock.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.

Receive News & Ratings for Albemarle Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Brokerages Set Ameresco Inc  PT at $13.17
Brokerages Set Ameresco Inc PT at $13.17
Brokerages Set Gaia, Inc.  Target Price at $21.50
Brokerages Set Gaia, Inc. Target Price at $21.50
Brokerages Anticipate Chesapeake Energy Co.  Will Announce Earnings of $0.13 Per Share
Brokerages Anticipate Chesapeake Energy Co. Will Announce Earnings of $0.13 Per Share
Safe Exchange Coin  Trading Up 6.8% Over Last 7 Days
Safe Exchange Coin Trading Up 6.8% Over Last 7 Days
NevaCoin  Price Tops $0.0623 on Major Exchanges
NevaCoin Price Tops $0.0623 on Major Exchanges
$1.87 Billion in Sales Expected for American Axle  This Quarter
$1.87 Billion in Sales Expected for American Axle This Quarter


Leave a Reply

© 2006-2018 Ticker Report. Google+.